212 related articles for article (PubMed ID: 27879264)
21. 4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.
De A; Jacobson BA; Peterson MS; Jay-Dixon J; Kratzke MG; Sadiq AA; Patel MR; Kratzke RA
Invest New Drugs; 2018 Apr; 36(2):217-229. PubMed ID: 29116477
[TBL] [Abstract][Full Text] [Related]
22. eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling.
Attar-Schneider O; Pasmanik-Chor M; Tartakover-Matalon S; Drucker L; Lishner M
Oncotarget; 2015 Feb; 6(6):4315-29. PubMed ID: 25717031
[TBL] [Abstract][Full Text] [Related]
23. Evaluating the conformation and binding interface of cap-binding proteins and complexes via ultraviolet photodissociation mass spectrometry.
O'Brien JP; Mayberry LK; Murphy PA; Browning KS; Brodbelt JS
J Proteome Res; 2013 Dec; 12(12):5867-77. PubMed ID: 24200290
[TBL] [Abstract][Full Text] [Related]
24. Targeting the eIF4F translation initiation complex for cancer therapy.
Konicek BW; Dumstorf CA; Graff JR
Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377
[TBL] [Abstract][Full Text] [Related]
25. Decreased expression of EIF4A1 after preoperative brachytherapy predicts better tumor-specific survival in cervical cancer.
Liang S; Zhou Y; Chen Y; Ke G; Wen H; Wu X
Int J Gynecol Cancer; 2014 Jun; 24(5):908-15. PubMed ID: 24844222
[TBL] [Abstract][Full Text] [Related]
26. mRNA- and factor-driven dynamic variability controls eIF4F-cap recognition for translation initiation.
Çetin B; O'Leary SE
Nucleic Acids Res; 2022 Aug; 50(14):8240-8261. PubMed ID: 35871304
[TBL] [Abstract][Full Text] [Related]
27. Manipulation of the host translation initiation complex eIF4F by DNA viruses.
Walsh D
Biochem Soc Trans; 2010 Dec; 38(6):1511-6. PubMed ID: 21118117
[TBL] [Abstract][Full Text] [Related]
28. Evolutionary changes in the Leishmania eIF4F complex involve variations in the eIF4E-eIF4G interactions.
Yoffe Y; Léger M; Zinoviev A; Zuberek J; Darzynkiewicz E; Wagner G; Shapira M
Nucleic Acids Res; 2009 Jun; 37(10):3243-53. PubMed ID: 19321500
[TBL] [Abstract][Full Text] [Related]
29. Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma.
Jiang CC; Croft A; Tseng HY; Guo ST; Jin L; Hersey P; Zhang XD
Oncogene; 2014 May; 33(20):2577-88. PubMed ID: 23770856
[TBL] [Abstract][Full Text] [Related]
30. Selective modification of eukaryotic initiation factor 4F (eIF4F) at the onset of cell differentiation: recruitment of eIF4GII and long-lasting phosphorylation of eIF4E.
Caron S; Charon M; Cramer E; Sonenberg N; Dusanter-Fourt I
Mol Cell Biol; 2004 Jun; 24(11):4920-8. PubMed ID: 15143184
[TBL] [Abstract][Full Text] [Related]
31. The 4E-BP Caf20p Mediates Both eIF4E-Dependent and Independent Repression of Translation.
Castelli LM; Talavera D; Kershaw CJ; Mohammad-Qureshi SS; Costello JL; Rowe W; Sims PF; Grant CM; Hubbard SJ; Ashe MP; Pavitt GD
PLoS Genet; 2015 May; 11(5):e1005233. PubMed ID: 25973932
[TBL] [Abstract][Full Text] [Related]
32. RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes.
Robert F; Cencic R; Cai R; Schmeing TM; Pelletier J
Nucleic Acids Res; 2020 Sep; 48(15):8562-8575. PubMed ID: 32749456
[TBL] [Abstract][Full Text] [Related]
33. A unique phosphorylation-dependent eIF4E assembly on 40S ribosomes co-ordinated by hepatitis C virus protein NS5A that activates internal ribosome entry site translation.
Panda S; Vedagiri D; Viveka TS; Harshan KH
Biochem J; 2014 Sep; 462(2):291-302. PubMed ID: 24894874
[TBL] [Abstract][Full Text] [Related]
34. A Cap for Every Occasion: Alternative eIF4F Complexes.
Ho JJD; Lee S
Trends Biochem Sci; 2016 Oct; 41(10):821-823. PubMed ID: 27283511
[TBL] [Abstract][Full Text] [Related]
35. The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment.
Bartish M; Abraham MJ; Gonçalves C; Larsson O; Rolny C; Del Rincón SV
Nat Rev Cancer; 2023 Jun; 23(6):408-425. PubMed ID: 37142795
[TBL] [Abstract][Full Text] [Related]
36. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
Ptushkina M; von der Haar T; Karim MM; Hughes JM; McCarthy JE
EMBO J; 1999 Jul; 18(14):4068-75. PubMed ID: 10406811
[TBL] [Abstract][Full Text] [Related]
37. A novel inhibitor of cap-dependent translation initiation in yeast: p20 competes with eIF4G for binding to eIF4E.
Altmann M; Schmitz N; Berset C; Trachsel H
EMBO J; 1997 Mar; 16(5):1114-21. PubMed ID: 9118949
[TBL] [Abstract][Full Text] [Related]
38. Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation.
Vary TC; Lynch CJ
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E631-42. PubMed ID: 16263769
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
Wan J; Shi F; Xu Z; Zhao M
Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
[TBL] [Abstract][Full Text] [Related]
40. Cellular stress in xenopus kidney cells enhances the phosphorylation of eukaryotic translation initiation factor (eIF)4E and the association of eIF4F with poly(A)-binding protein.
Fraser CS; Pain VM; Morley SJ
Biochem J; 1999 Sep; 342 Pt 3(Pt 3):519-26. PubMed ID: 10477262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
